Adverse events and safety
ADVERSE EVENTS
One participant experienced delayed menstruation after γ-Toc consumption; however, no other adverse events were observed. There were no significant between-supplement differences in serum sodium, serum potassium, osmolality, protein concentration, hemoglobin, and hematocrit levels in the mornings of E-D1 and E-D3. Moreover, there was no significant between-supplement difference in the rate of change in plasma volume from E-D1 morning to E-D3 morning.